An improved implantable prosthetic device for use in the human body which comprises a flexible container having therein a soft gel or fluid filling and an outer plastic covering bonded or otherwise connected to the flexible container. The external surface of the outer plastic covering is rough textured, while the plastic covering itself has numerous pores or interstices. It substantially encases the flexible container. In one embodiment a barrier film is positioned between the flexible container and the outer plastic covering or between the soft gel or liquid filling and the internal of the flexible container. The outer plastic covering is made of Dacron or Teflon.

Patent
   RE35391
Priority
Aug 30 1984
Filed
Oct 15 1992
Issued
Dec 03 1996
Expiry
Dec 03 2013
Assg.orig
Entity
Small
108
4
all paid
1. In an implantable prosthetic device for use in a human body including a flexible container and a soft gel or liquid filling the flexible container;
the improvement which comprises providing an outer plastic covering made of rough textured silicone and bonded to the flexible container, said outer plastic convering covering having a rough textured external surface thereby providing a multiplicity of pores and/or interstices to permit tissue ingrowth, said outer plastic covering encases the flexible container in order to prevent the contraction of scar tissue around the prosthetic device from pulling the prosthetic device into a hard, spherical shape.
2. In the implantable prosthetic device of claim 1 wherein a barrier film is positioned between the flexible container and the outer plastic covering having said rough, textured external surface or inside the flexible container.
3. In the implantable prosthetic device of claim 2 wherein said barrier film is a fluororubber.
4. In a breast prosthesis comprising a flexible container approximating the shape of the human breast and a soft gel or liquid filling said container;
the improvement which comprises providing an outer, rough textured plastic covering made of rough textured silicone and which encases the flexible container and has an outer surface having a multiplicity of pores and/or interstices to permit tissue ingrowth. 5. In the breast prosthesis of claim 4, wherein said outer rough textured plastic covering and said flexible container comprise a single integral member.6. In the implantable prosthetic device of claim 1, wherein said outer plastic covering and said flexible container comprise a single integral member.

This application is a continuation of U.S. patent application Ser. No. 12,583, filed Feb. 9, 1987, abandoned, which was a divisional of earlier filed U.S. patent application Ser. No. 630,124, filed Aug. 30, 1984, now U.S. Pat. No. 4,648,880.

The present invention relates to improved implantable prostheses which resist spherical capsular contracture. More particularly, the invention pertains to improved prosthetic devices for rescoring or improving normal body contour or augmenting as well as reconstructing the female breast. It may also be used to augment or reconstructing tissue on various locations on the human body.

In recent years one of the most popular implantable procedures was a gel-filled silicon bag. This prosthesis has been employed for a number of years for breat augmentation and reconstruction. In. U.S. Pat. No. 3,293,663 to Cronin, the breast prosthesis comprises (1) a flexible container approximating the shape of the human breast, (2) a soft gel filling said container, and (3) a layer of porous material attached to one side of said container so that the tissue can grow into said porous material to another the prosthesis to the chest wall.

U.S. Pat. Nos. 4,205,401 to Frisch and 4,264,990 to Hamas reveals that when a Cronin-type of prosthesis is implanted after a certain period of time the prosthesis is surrounded by a natural capsule composed of fibrous scar tissue. Although this is a normal tissue reaction to the presence of a foreign body, it has the disadvantage in that the scar may undergo contraction during the healing process. This effect, which is known as the sperical contracture of the prosthesis, leads to a relatively rigid and tense structure. More specifically, as the tissue around the implant contracts the fixed volume of the silicon gel and material within the flexible container is forced into a shape having the smallest possible surface area, i.e. a sphere surrounded by essentially scar tissue. As pointed as by Frisch, the resulting hard spherical prosthesis results in an aesthically undesirable breast.

Both the Frisch and Hamas disclose various prior art efforts to overcome the spherical capsular contracture problem. Disadvantages of the piror art suggestions are also discussed by the patentees. Frisch's invention is to resist capsular contracture by employing a flexible container which has structural restraining means positioned within the container or the container walls which function to restrain the scar tissue pressure. On the other hand, Hamas proposes the use of a special flexible backing of an inert polymeric material which defines passageways and/or compartments into which a second material may be injected or already placed to rigidfy the backing. This is somewhat of an attempted improvement over the Cronin device which uses a back porous layer such as a Dacron fabric. There are many other proposed suggestions, but they were also found to have disadvantages and flaws.

Thus,the devices heretofore proposed for overcoming the capsular contracture problem has not been found to be effective. It is also very important that the implant can be readily removed in its entirety from the human body in the even that an infection or undesirable reaction to the implant occurs or should total repositioning or total removal be desired for whatever reason.

The present invention is directed to improved implantable prosthesis for use in the human body comprising a flexible container with a soft gel or fluid filling and an outer plastic or polymeric covering bonded to the flexible container and substantially encompassing said container. The outer plastic polymeric covering is made from Dacron or Teflon and has numerous pores or interstices as well as a rough textured external surface. It is also possible to employ a barrier film or membrane disposed between the flexible container and the outer covering or positioned within the flexible container.

One object of the present invention to provide an implantable prosthesis whichg will disperse or disorganize the force of encapsulating tissue sufficient to avoid formation of a spherical capsular contracture.

Another object of the present invention is to provide an implantable prosthesis which can readily be removed in its entirety, if desired, from the human body without encountering any untoward affects.

A further object of the present invention is to provide an improved mammary prosthesis which avoids or substantially decreases the formation of a spherical capsular contracture.

The above objects and advantages of the present invention will be more fully understood by reference to the following description and to the annexed drawing, in which:

FIG. 1 shows an implantable breast prosthesis having a soft gel filling a flexible container and an outer covering with a rough textured external surface.

FIG. 2 shows an implantable breast prosthesis having a soft gel filling, a barrier film, a flexible container, and an outer covering with a rough textured external surface.

The invention will be described more specifically with respect to a mammary proshesis including a flexible container, envelope, or sac filled with a gel or any of the other conventional materials utilized in this art. The flexible container is formed of a flexible silicon rubber or Silastic membrane and the gel, for example, is a semi-fluid silicone or liquid methylsiloxane resin capable of having a consistency which will provide resiliency and maintain the proper contour of the container. As known in the art, any suitable materials which do not cause tissue reaction and which are soft and flexible can be utilized for these purposes. For the present purposes, however, the preferred material for the flexible material is silicon rubber while the preferred gel is a silicon gel. Such material will often exhibit an elastic memory. The disclosure in column 2, line 32-46, of U.S. Pat. No. 3,293,663 is incorporated herein by reference with respect to the gel material that can be employed.

The container itself may be formed of a physiological inert elastomeric material which includes a number of known plastics. As previously stated, the use of silicon rubber is preferred, but for certain purposes organic rubbers made from butyl polymer or the natural polymer from the Hevea tree could be effectively employed. The use of dimethylsiloxane polymer to form the flexible container is also encompassed.

The thickness of the container wall will generally range from about 0.025 to 0.5 millimeters, but it can vary widely. In general, the flexible contianer is filled with a silicon gel or, if desired, with the saline solutions which have been recently proposed for this purpose, in amounts sufficiant to give the prosthesis a pilant, responsive nature as well as the desired profile.

A conventional barrier, film or membrane may be bonded laminated or adhesively connected to the internal or external wall of the flexible container to eliminate any seepage of the filler material out of the wall of the flexible container. It may be made of materials such as a vinyldene fluoridehexafluoropropylene-based fluoro-rubber as disclosed in U.S. Pat. No. 4,413,359.

The essential feature of the present invention is the use of an outer plastic or polymeric covering for the flexible bag or the flexible bag provided with a barrier film or membrane. Thus, the nature of the flexible container, the material used to fill it, and the barrier film are less important than the external surface of the plastic or polymeric covering as well as its nature. In order to overcome the spherical capsular contracture discussed above, the external or outer surface of the polymeric film or plastic film has to be rough textured as well as being able to permit tissue ingrowth. Thus, the rough texture of the external surface, which will have pores or interstices, will break up the orderly alignment of the collagen fibers in the scar or fibrous capsule surrounding the implanted prostesis. Although at this time it is not fully understood how this outer covering with the special external surface functions, it is believed that it is the orderly alignment of the collagen in the fibrous capsules around the smooth prosthesis implant which cause spherical capsular contraction. In the present invention this orderly alignment is disrupted or disorganized.

In accordance with another feature of the present invention it has been found that despite the rough textured external surface of the outer convering the implant can be completely removed without any problems in the event of an infection or otherwise indicated or undesired.

The preferred material for use as the outer covering is polyester fibers such as Dacron which is a polymerized ethylene glycol terephthalate. Although the polyester fiber may be woven, knitted, braided or formed into felt; the use of knitted polyester fiber is found to be superior because it provides more elasticity and tissue in growth. Knitted Dacron velour is the especially preferred material, since the velour structure may further assist in disrupting or disorganizing the orderly alignment of the collagen fibers. It may be crimped to additional elasticity.

In accordance with another feature of this invention it has been found that tetrafluoroethylene polymer such as Teflon, can also be utilized for the purposes of preparing an improved implantable prosthesis which will resist spherical capsular contracture. The polymeric material is most useful when it is employed in its expanded from. Such an expanded Teflon is sold commercially under the name Gortex.

The outer covering will of course be bonded, laminated or adhesively secured to the flexible container or to the outer surface of the intermediate barrier film when the later is employed in this position. The thickness of the outer covering and may vary over a wide range. Thus, for example, it may have a thickness of from about 0.01 to 1 millimeter. By a "rough textured" outer surface it is meant that the external surface of the outer covering will, by its nature, have numerous pores and/or interstices. If velour is used, fibers will project out from the external surface of the covering. Both the size and number of the pores and interstices may vary, but it is important that substantial pores and/or interstices be present in order to obtain the desired benefit or the present invention.

Although the invention has been described above with respect to certain of its more important features, it will be understood that the invention is subject to variations and modifications without departing from its broader scope. Thus, for example, in addition to mammary prosthesis the improved implantable devices of this invention can also be used for different shapes and forms for the purpose of augmenting tissue anywhere on the animal or human body for aestetic and reconstructive purposes. Augmentation of tissue include augmentation of hypoplastic or missing tissure for reconstructive purposes as well as the augmentation of tissue for aesthetic purposes. It is also possible, for example, to use silicone foam or a rough textured silicon envelope as the external covering, but at the present time they are not preferred materials for the present purposes.

Brauman, Daniel

Patent Priority Assignee Title
10045832, May 23 2003 SenoRx, Inc. Marker or filler forming fluid
10058416, Oct 10 1997 SenoRx, Inc. Tissue marking implant
10092392, May 16 2014 Allergan, Inc. Textured breast implant and methods of making same
10172674, Feb 02 1999 SenoRx, Inc. Intracorporeal marker and marker delivery device
10258428, Dec 30 2008 C. R. Bard, Inc. Marker delivery device for tissue marker placement
10299881, May 23 2003 Senorx, Inc Marker or filler forming fluid
10342635, Apr 20 2005 Bard Peripheral Vascular, Inc.; Bard Shannon Limited Marking device with retractable cannula
10350055, May 16 2014 Allergan, Inc. Textured breast implant and methods of making same
10357328, Apr 20 2005 Bard Peripheral Vascular, Inc; Bard Shannon Limited Marking device with retractable cannula
10391199, Feb 05 2010 Allergan, Inc. Porous materials, methods of making and uses
10463446, Jun 17 1999 Bard Peripheral Vascular, Inc; Bard Shannon Limited Apparatus for the percutaneous marking of a lesion
10624997, Feb 05 2010 Allergan, Inc. Porogen compositions, methods of making and uses
10675144, Aug 13 2008 Allergan, Inc. Soft filled prosthesis shell with discrete fixation surfaces
10682200, Dec 12 2006 C. R. Bard, Inc. Multiple imaging mode tissue marker
10765501, Aug 13 2008 Allergan, Inc. Dual plane breast implant
10786604, Sep 23 2008 SenoRx, Inc. Porous bioabsorbable implant
10813716, Nov 18 2002 Bard Peripheral Vascular, Inc.; Bard Shannon Limited Self-contained, self-piercing, side-expelling marking apparatus
10864661, Dec 13 2012 Allergan, Inc. Device and method for making a variable surface breast implant
11202853, May 11 2010 Allergan, Inc. Porogen compositions, methods of making and uses
11278370, Apr 20 2005 Bard Peripheral Vascular, Inc. Marking device with retractable cannula
11471244, Dec 12 2006 C.R. Bard, Inc. Multiple imaging mode tissue marker
11779431, Dec 30 2008 C. R. Bard, Inc. Marker delivery device for tissue marker placement
11833275, Sep 23 2008 SenoRx, Inc. Porous bioabsorbable implant
6214045, Oct 10 1997 Senorx, Inc Bioabsorbable breast implant
6436143, Feb 22 1999 NuVasive, Inc Method and apparatus for treating intervertebral disks
6605116, Apr 03 2001 Mentor Worldwide LLC Reinforced radius mammary prostheses and soft tissue expanders
6638308, Oct 10 1997 Senorx, Inc Bioabsorbable breast implant
6881226, Oct 10 1997 Senorx, Inc; WHITEWATER INVESTMENTS, INC Bioabsorbable breast implant
7044957, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Devices for defining and marking tissue
7229417, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Methods for marking a biopsy site
7244270, Sep 16 2004 EVERA MEDICAL, INC Systems and devices for soft tissue augmentation
7625397, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Methods for defining and marking tissue
7637948, Oct 10 1997 Senorx, Inc; WHITEWATER INVESTMENTS, INC Tissue marking implant
7641688, Sep 16 2004 EVERA MEDICAL, INC Tissue augmentation device
7645475, Mar 03 2004 Mentor Worldwide LLC Devices having a textured surface
7846205, Sep 03 2003 System and method for breast augmentation
7871438, Oct 10 1997 SenoRx, Inc. Tissue marking implant
7998201, Sep 16 2004 Evera Medical, Inc. Methods of forming a tissue implant having a tissue contacting layer held under compression
7998202, Sep 16 2004 Evera Medical, Inc. Tissue implant having a biased layer and compliance that simulates tissue
8092527, Sep 03 2003 System and method for breast augmentation
8157862, Oct 10 1997 SenoRx, Inc. Tissue marking implant
8177792, Jun 17 2002 Senorx, Inc Plugged tip delivery tube for marker placement
8202316, Jan 29 2008 Modulating buttress saline mammary prosthesis
8219182, Feb 02 1999 Senorx, Inc Cavity-filling biopsy site markers
8224424, Feb 02 1999 Senorx, Inc Tissue site markers for in vivo imaging
8277391, Sep 16 1994 DEVICOR MEDICAL PRODUCTS, INC Methods and devices for defining and marking tissue
8288745, Oct 10 1997 Senorx, Inc; WHITEWATER INVESTMENTS, INC Method of utilizing an implant for targeting external beam radiation
8311610, Jan 31 2008 C. R. Bard, Inc.; C R BARD, INC Biopsy tissue marker
8361082, Feb 02 1999 Senorx, Inc Marker delivery device with releasable plug
8401622, Dec 18 2006 C R BARD, INC Biopsy marker with in situ-generated imaging properties
8437834, Oct 23 2006 C. R. Bard, Inc. Breast marker
8447386, May 23 2003 SenoRx, Inc. Marker or filler forming fluid
8486028, Oct 07 2005 Bard Peripheral Vascular, Inc. Tissue marking apparatus having drug-eluting tissue marker
8498693, Feb 02 1999 SenoRx, Inc. Intracorporeal marker and marker delivery device
8506627, Aug 13 2008 Allergan, Inc Soft filled prosthesis shell with discrete fixation surfaces
8541764, Oct 10 1997 SenoRx, Inc. Method of utilizing an implant for targeting external beam radiation
8546458, Dec 07 2010 Allergan, Inc Process for texturing materials
8579931, Jun 17 1999 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
8626269, May 23 2003 SenoRx, Inc. Fibrous marker and intracorporeal delivery thereof
8626270, Feb 02 1999 SenoRx, Inc. Cavity-filling biopsy site markers
8634899, Nov 17 2003 Bard Peripheral Vascular, Inc; Bard Shannon Limited Multi mode imaging marker
8639315, May 23 2003 SenoRx, Inc. Marker or filler forming fluid
8668737, Oct 10 1997 SenoRx, Inc. Tissue marking implant
8670818, Dec 30 2008 C. R. Bard, Inc.; C R BARD, INC Marker delivery device for tissue marker placement
8679279, Nov 16 2010 Allergan, Inc. Methods for creating foam-like texture
8679570, Apr 27 2010 Allergan, Inc Foam-like materials and methods for producing same
8680498, Oct 10 1997 SenoRx, Inc. Method of utilizing an implant in a human breast
8685296, May 11 2010 Allergan, Inc Porogen compositions, method of making and uses
8718745, Nov 20 2000 Senorx, Inc Tissue site markers for in vivo imaging
8784433, Jun 17 2002 SenoRx, Inc. Plugged tip delivery tube for marker placement
8877822, Sep 28 2010 Allergan, Inc Porogen compositions, methods of making and uses
8880154, May 23 2003 SenoRx, Inc. Fibrous marker and intracorporeal delivery thereof
8889751, Sep 28 2010 Allergan, Inc Porous materials, methods of making and uses
8911765, Mar 29 2007 Medtronic, Inc Biodegradable, polymer coverings for breast implants
8951596, Oct 16 2009 Allergan, Inc. Implants and methods for manufacturing same
8965486, Feb 02 1999 SenoRx, Inc. Cavity filling biopsy site markers
9039763, Oct 10 1997 SenoRx, Inc. Tissue marking implant
9042965, Dec 18 2006 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
9044162, Feb 02 1999 SenoRx, Inc. Marker delivery device with releasable plug
9044897, Sep 28 2010 Allergan, Inc Porous materials, methods of making and uses
9072821, Feb 05 2010 Allergan, Inc Biocompatible structures and compositions
9138308, Feb 03 2010 Boston Scientific Scimed, Inc; APOLLO ENDOSURGERY, INC Mucosal tissue adhesion via textured surface
9138311, Aug 13 2008 Allergan, Inc. Soft filled prosthesis shell with discrete fixation surfaces
9149341, Feb 02 1999 Senorx, Inc Deployment of polysaccharide markers for treating a site within a patient
9155613, Nov 16 2010 Allergan, Inc. Methods for creating foam-like texture
9237937, Feb 02 1999 SenoRx, Inc. Cavity-filling biopsy site markers
9327061, Sep 23 2008 Senorx, Inc Porous bioabsorbable implant
9333070, Feb 01 2008 Evera Medical, Inc. Breast implant with internal flow dampening
9393106, Aug 13 2008 Allergan, Inc. Soft filled prosthesis shell with discrete fixation surfaces
9480554, Oct 10 1997 SenoRx, Inc. Tissue marking implant
9522502, Sep 28 2010 Allergan, Inc. Porous materials, methods of making and uses
9579077, Dec 12 2006 C R BARD, INC Multiple imaging mode tissue marker
9579159, Jun 17 1999 Bard Peripheral Vascular, Inc.; Bard Shannon Limited Apparatus for the percutaneous marking of a lesion
9593224, Sep 28 2010 Allergan, Inc. Porogen compositions, methods of making and uses
9649093, Feb 02 1999 SenoRx, Inc. Cavity-filling biopsy site markers
9688006, Dec 13 2012 Allergan, Inc Device and method for making a variable surface breast implant
9801688, May 23 2003 SenoRx, Inc. Fibrous marker and intracorporeal delivery thereof
9820824, Feb 02 1999 SenoRx, Inc. Deployment of polysaccharide markers for treating a site within a patent
9848956, Nov 18 2002 Bard Peripheral Vascular, Inc.; Bard Shannon Limited Self-contained, self-piercing, side-expelling marking apparatus
9848972, Aug 13 2008 Allergan, Inc Dual plane breast implant
9861294, Feb 02 1999 SenoRx, Inc. Marker delivery device with releasable plug
9901415, Dec 12 2006 C. R. Bard, Inc. Multiple imaging mode tissue marker
9918829, Aug 13 2008 Allergan, Inc. Soft filled prosthesis shell with discrete fixation surfaces
D715442, Sep 24 2013 C. R. Bard, Inc.; C R BARD, INC Tissue marker for intracorporeal site identification
D715942, Sep 24 2013 C. R. Bard, Inc.; C R BARD, INC Tissue marker for intracorporeal site identification
D716450, Sep 24 2013 C. R. Bard, Inc.; C R BARD, INC Tissue marker for intracorporeal site identification
D716451, Sep 24 2013 C. R. Bard, Inc.; C R BARD, INC Tissue marker for intracorporeal site identification
RE43434, Feb 22 1999 NuVasive, Inc Method and apparatus for treating intervertebral disks
Patent Priority Assignee Title
3559214,
3700380,
4413359, Mar 04 1981 Koken Co., Ltd. Impermeable laminate membrane
4455691, Oct 03 1979 APPALOOSA MANAGEMENT L P Silicone gel filled prosthesis
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 28 2004BRAUMAN, DANIELMentor CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0157110016 pdf
Date Maintenance Fee Events
Apr 15 1998M284: Payment of Maintenance Fee, 8th Yr, Small Entity.
Apr 22 1998ASPN: Payor Number Assigned.
Nov 19 2001M285: Payment of Maintenance Fee, 12th Yr, Small Entity.
Jun 07 2002ASPN: Payor Number Assigned.
Jun 07 2002RMPN: Payer Number De-assigned.


Date Maintenance Schedule
Dec 03 19994 years fee payment window open
Jun 03 20006 months grace period start (w surcharge)
Dec 03 2000patent expiry (for year 4)
Dec 03 20022 years to revive unintentionally abandoned end. (for year 4)
Dec 03 20038 years fee payment window open
Jun 03 20046 months grace period start (w surcharge)
Dec 03 2004patent expiry (for year 8)
Dec 03 20062 years to revive unintentionally abandoned end. (for year 8)
Dec 03 200712 years fee payment window open
Jun 03 20086 months grace period start (w surcharge)
Dec 03 2008patent expiry (for year 12)
Dec 03 20102 years to revive unintentionally abandoned end. (for year 12)